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Abstract
Introduction Veno-arterial extracorporeal membrane
oxygenation (VA-ECMO) is a cardio-pulmonary bypass
technique to provide life support in acute reversible cardio-
respiratory failure when conventional management is not
successful. Most neonates receiving ECMO suffer from
meconium aspiration syndrome (MAS), congenital
diaphragmatic hernia (CDH), sepsis or persistent pulmonary
hypertension (PPH). In five-year-old children who underwent
VA-ECMO therapy as neonates, we assessed motor
performance related to growth, intelligence and behaviour, and
the association with the primary diagnosis.
Methods In a prospective population-based study (n = 224)
174 five-year-old survivors born between 1993 and 2000 and
treated in the two designated ECMO centres in the Netherlands
(Radboud University Medical Centre Nijmegen and Sophia
Children's Hospital, Erasmus MC – University Medical Center
Rotterdam) were invited to undergo follow-up assessment
including a paediatric assessment, the movement assessment
battery for children (MABC), the revised Amsterdam intelligence
test (RAKIT) and the child behaviour checklist (CBCL).
Results Twenty-two percent of the children died before the age
of five, 86% (n = 149) of the survivors were assessed. Normal
development in all domains was found in 49% of children.
Severe disabilities were present in 13%, and another 9% had
impaired motor development combined with cognitive and/or
behavioural problems. Chi-squared tests showed adverse
outcome in MABC scores (P  < 0.001) compared with the
reference population in children with CDH, sepsis and PPH, but
not in children with MAS. Compared with the Dutch population
height, body mass index (BMI) and weight for height were lower
in the CDH group (P < 0.001). RAKIT and CBCL scores did not
differ from the reference population. Total MABC scores, socio-
economic status, growth and CBCL scores were not related to
each other, but negative motor outcome was related to lower
intelligence quotient (IQ) scores (r = 0.48, P < 0.001).
Conclusions The ECMO population is highly at risk for
developmental problems, most prominently in the motor domain.
Adverse outcome differs between the primary diagnosis groups.
Objective evaluation of long-term developmental problems
associated with this highly invasive technology is necessary to
determine best evidence-based practice. The ideal follow-up
programme requires an interdisciplinary team, the use of normal-
referenced tests and an international consensus on timing and
actual outcome measurements.
BMI: body mass index; CBCL: child behaviour checklist; CDH: congenital diaphragmatic hernia; ECMO: extracorporeal membrane oxygenation; EEG: 
electroencephalography; IQ: intelligence quotient; MABC: movement assessment battery for children; MAS: meconium aspiration syndrome; PPH: 
persistent pulmonary hypertension; RAKIT: revised Amsterdam intelligence test; SD: standard deviation; VA-ECMO: veno-arterial extracorporeal 
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Introduction
Extracorporeal membrane oxygenation (ECMO) is an effective
treatment for respiratory failure in neonates suffering from
meconium aspiration syndrome (MAS), congenital diaphrag-
matic hernia (CDH), sepsis or persistent pulmonary hyperten-
sion (PPH).
ECMO is associated with high survival rates (76%) [1,2]. Nev-
ertheless, survivors may suffer from long-term morbidity such
as pulmonary dysfunction and cerebral damage, depending on
the severity of primary illness and respiratory failure prior to
ECMO and several factors during ECMO [3-5]. Prediction of
long-term outcome after ECMO is not easy. Although neonatal
brain injury tends to affect neuropsychological status at five
years of age, evidence of functional recovery following brain
injury has also been found [6,7].
Most studies in ECMO survivors have so far focused on the
health status at the age of one to three years [1,3,8-10]. Per-
centages of abnormal outcome in these studies differ, proba-
bly as a result of differences in study populations, assessment
procedures and inclusion criteria. The range of morbidity wid-
ens after the first year of life when more precise assessment of
cognition, coordination and behaviour is feasible. Long-term
longitudinal follow-up would therefore seem essential for eval-
uating ECMO results [11,12]. Only a few studies have
focused on neuromotor outcome from the age of four years
and none of these analysed the relation between motor per-
formance and health condition, cognition and behaviour [12-
14].
Previously, we presented the overall morbidity in Dutch ECMO
survivors at the age of five years [15]. Six of the 98 children
had major disabilities and 24 of the remaining 92 (26%)
showed motor problems. The present study aims to evaluate
in detail the characteristics of motor performance at five years
of age in a larger Dutch ECMO population. We hypothesised
that the motor performance profile is associated with the pri-
mary diagnosis. Moreover, we analysed the relations between
motor performance problems, health status, cognitive and
behavioural problems.
Materials and methods
Patients
A population who had received veno-arterial (VA)-ECMO sup-
port within 28 days of birth in either of the two ECMO centres
in the Netherlands (Radboud University Medical Centre
Nijmegen and Sophia Children's Hospital, Erasmus MC – Uni-
versity Medical Center Rotterdam) between January 1993
(Nijmegen) or 1996 (Rotterdam) and December 2000 (n =
224) and were alive at age five years (n = 174) were invited to
undergo follow-up assessment (Figure 1). Neonatal data had
been prospectively collected in an ECMO database.
According to a national consensus on neonatal follow-up and
the obligation to provide these data based on reports of the
Dutch Ministry of Health, the assessment protocol is the Dutch
standard of care in ECMO follow-up [16,17]. As a conse-
quence no written informed consent from the parents was
necessary. All parents were routinely informed about the long-
term follow-up programme and use of anonymous data for
study proposal in the neonatal period of life and again when
they were invited for the assessments at the age of five years.
The ethical review boards in both Medical Centres were
informed and agreed with the study.
Assessment protocol
Perinatal characteristics (Table 1) were recorded as submitted
to the Extracorporeal Life Support Organization registry [2]. A
paediatrician, a paediatric physical therapist and a child psy-
chologist assessed the five-year-olds during a single clinic
visit.
Questionnaires
Parents completed a questionnaire evaluating the child's
health status and employment and education of both parents.
Three socio-economic classes were defined using the stand-
ard Dutch profession classification [18].
Paediatrician's assessment
The paediatrician performed a physical examination and took a
medical history. Growth parameters were expressed in stand-
ard deviation (SD) scores using the Dutch Growth Analyser,
version 3.0 (Dutch Growth Foundation, Rotterdam, the Neth-
erlands).
Motor performance assessment
A paediatric physical therapist administered the movement
assessment battery for children (MABC). It assesses skills
related to motor functioning in daily life. The MABC has four
age bands each with eight items grouped into three perform-
ance sections: manual dexterity (three items), ball skills (two
items) and static and dynamic balance (three items). All items
are scored quantitatively (duration in seconds or number of
hits or errors). Section scores for manual dexterity, ball skills
and static and dynamic balance, and a total impairment score
can be calculated, with lower scores indicating better perform-
ance. Scores can be interpreted using the percentile normal
data tables in the manual [19,20]. Scores above the 15th per-
centile are considered 'normal', between 5th and 15th percen-
tile is considered 'borderline', and below the 5th percentile is
'definitively delayed'. A Dutch version of the test is available:
interrater reliability ranges from 0.70 to 0.89, while test–retest
reliability is 0.75 [19,20]. The test is the most frequently used
test to identify children with functional motor problems
[19,21,22].Available online http://ccforum.com/content/13/2/R47
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Figure 1
Flowchart of children included in the VA-ECMO follow-up programme at the age of five years Flowchart of children included in the VA-ECMO follow-up programme at the age of five years. CBCL = child behaviour checklist; MABC = move-
ment assessment battery for children; RAKIT = revised Amsterdam intelligence test; VA-ECMO = veno-arterial extracorporeal membrane oxygena-
tion.
149  
children participated in the ECMO follow-up program 
Lost to follow-up:  
n = 25 
10 unknown residences 
8  no consent   
4 other reason (travelling 
distance, illness, etc.) 
1 known syndrome 
2 unknown reasons
50 neonates died 
174 eligible for follow-up 
224 
Neonates received VA-ECMO support between 
January 1998 and December 2000 
131 children were completely tested 
with the RAKIT  
 
2 not tested for unknown reason 
2 parents refused intelligence tests  
7 test results not reliable  
3 children stopped during 
testing 
4 children with language 
problems  
140 children were tested 
with the MABC 
  
2 with hemiplegia could 
not perform the MABC
7 children unable to perform all tests functioning below age 
in all domains: 
 
5 with cerebral Palsy: 2 hemiplegia, 3 quadriplegia 
1 with Down syndrome 
1 with chorea/athetosis and severe mental retardation 
125 parents completed the 
CBCL  
 
4 missing for unknown reason 
3 parents refused (1 child with 
known behavioural problems) 
7 parents with language 
problems 
3 incomplete questionnaires Critical Care    Vol 13 No 2    Nijhuis-van der Sanden et al.
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Cognitive assessment and behaviour
A psychologist (assistant) assessed cognitive development
with the short version of the revised Amsterdam intelligence
test (RAKIT) – a reliable, validated, normal-referenced Dutch
instrument containing six subtests [23]. Raw subtest scores
are converted into standardised scores, which are then trans-
formed into a short RAKIT intelligence quotient (IQ) with a
mean of 100 and a SD of 15. 'Mild cognitive delay' was
defined by a test result between -1 SD and -2 SD (IQ ≥ 70 and
< 85), and 'definitive delay' by a test result lower than -2 SD
(IQ < 70).
Behavioural outcome was assessed using the Dutch version
of the child behaviour checklist (CBCL) for children aged 4 to
18 years [24]. The CBCL is a validated parental questionnaire
and rates 113 problem behaviour items on a three-point scale
(0 = not true, 1 = somewhat true, 2 = very true). The sum of all
item scores results in a total score, which is recalculated into
a percentile score. Scores of 59 or less are classified as
'within normal range', scores 60 to 63 as 'borderline' and
scores 64 and above 'within clinical range'.
Data analysis
Independent t-tests or chi-squared tests were used to test dif-
ferences between the participating and non-participating chil-
dren and to test whether the ECMO population differed
significantly from the reference population in growth, motor
performance, intelligence and behaviour. Two-sample t-tests
and Mann-Whitney-U tests were used to examine the differ-
ences between diagnosis subgroups. Spearman correlations
between motor performance scores and growth data, intelli-
gence scores, behavioural scores and socio-economic status
were calculated. P values less than 0.05 were considered sta-
tistically significant. All analyses were performed using SPSS
version 16.
Results
As 25 of the 174 eligible children did not participate for vari-
ous reasons (Figure 1), 149 (86%) children underwent follow-
up assessment. The participating and non-participating
groups did not differ in perinatal and ECMO characteristics
(Table 1).
Patient characteristics at age five years are presented in Table
2. Mean and SD of height, SD of body mass index and SD of
weight-for-height scores for the total sample were significantly
lower than those for the Dutch reference population. Post-hoc
analysis revealed that growth was within the normal range in
the groups of children with sepsis and persistent pulmonary
hypertension (PPH). In the group of children with meconium
Table 1
Perinatal and extracorporeal membrane oxygenation (ECMO) characteristics of all survivors (N = 174)
Infants not participating (n = 25) Infants in follow-up (n = 149)
Male/Female1: number 17/8 87/62
Birth weight (g)2: mean (SD) 3272 (560) 3367 (604)
Gestational age (weeks)2: mean (SD) 38.6 (2.3) 39.5 (2.0)
Primary diagnoses1: number number
Meconium aspiration syndrome 13 75
Congenital diaphragmatic hernia 4 32
Sepsis 4 16
Persistent pulmonary hypertension 2 25
Pulmonary hypoplasia 2 1
Duration of the ECMO (hours)2: means (SD) 155 (57) 163 (64)
Neurological complications1: number 20 (5 missing) 120 (29 missing)
None 14 71
Haemorrhage 3 9
Cerebral infarction 0 6
Clinical epileptic insults 3 6
EEG epileptic insults 0 28
No differences were seen in perinatal characteristics between infants not participating and infants in follow-up;
1 Chi-squared test: P > 0.05; 2 Student t-test P > 0.05
EEG = electroencephalography; SD = standard deviation.Available online http://ccforum.com/content/13/2/R47
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aspiration syndrome (MAS) only SD of height was lower than
the normal range (P < 0.03), but in the congenital diaphrag-
matic hernia (CDH) population all three parameters were sig-
nificantly lower (P < 0.001): 23 children with CDH (72%) had
a weight for height lower than normal (50% < -1 SD, and 22%
< -2 SD). Visual problems were rare (n = 8) and previously
undetected in only one child. Hearing problems were also rare
(n = 8) and previously undetected in three children.
Motor performance
Seven children were unable to partake in the assessments
(Figure 1). Another two children with hemiparesis were not
able to perform the MABC, so 140 children were tested with
the MABC. Chi-squared tests revealed more motor problems
in these children than in the reference population (P < 0.001);
94 children (67% vs. 85% expected) scored within the normal
range, 23 children (16.5% vs. 10% expected) were classified
as 'borderline' and another 23 children (16.5% vs. 5%
expected) as 'definitively delayed'. Manual dexterity scores did
not differ from those for the reference population. The majority
of children (86%) were right-handed, as in the reference pop-
ulation. Proportions of children with ball skill problems were
larger than in the reference population (P < 0.001): 82 normal
(58% vs. 85% expected), 36 borderline (26% vs. 10%
expected) and 22 definitively delayed (16% vs. 5% expected).
The same held true for balance skills (P < 0.001): 93 normal
(66.5% vs. 85% expected), 24 borderline (17% vs. 10%
expected) and 23 definitively delayed (16.5% vs. 5%
expected).
Motor performance profiles differed between the primary diag-
nosis groups, as shown in Figure 2. All test results for the one
child with pulmonary hypoplasia were within the normal range
(data not presented).
In the group of children with MAS, MABC total impairment
scores and manual dexterity scores did not differ from the ref-
erence scores, although more problems with ball- and balance
skills were found. Also in the PPH group, manual dexterity
scores were not deviant. Nevertheless, MABC total impair-
ment scores in this group were deviant on account of prob-
lems with ball- and balance skills. In both the CDH and sepsis
group, motor performance was significantly lower in all
domains. The CDH group scored significantly worse than the
MAS group on MABC total impairment score (Z = -2.4, P <
0.02), balance skills (Z = -2.8, P < 0.01) and ball skills (Z = -
2.7,  P  < 0.01), but not on manual dexterity. Differences
between the other groups were not significant.
Intelligence and behavioural scores
One hundred and thirty-one children were assessed with the
RAKIT (Figure 1). The IQ scores (mean = 99.7, SD = 18.1, n
= 131) and the behavioural scores (mean = 50.2, SD = 9.9; n
= 125) did not differ from those for the reference population
(P > 0.05), neither in the total group nor in the primary diagno-
sis groups.
Motor performance relation with health status, 
cognition, behaviour and socio-economic status
Table 3 shows outcomes for the total group and for the pri-
mary diagnosis groups including the children not tested
because of already known severe disabilities. Mortality was
highest in the CDH group (41.9%) and lowest in the MAS
group (6.4%). The CDH group also showed lowest normal
outcome in all domains (37.5%) versus 52.6% in the MAS
group. Motor domain problems were the problems most fre-
quently encountered in the total group (39.3%), in 22% of all
cases combined with cognitive and behavioural problems.
Table 2
Basic characteristics of the assessed group at five years of age 
(n= 149)
Total group (n = 149)
mean (SD)
Age in months 62 (2.5)
Height score * -0.4 (1.1)
Weight for height score ** -0.3 (1.4)
BMI score *** -0.3 (1.4)
Motor performance percentile score (n = 140) 35.6 (28.4)
Intelligence score (n = 131) 99.7 (18.1)
Behavioural score (n = 125) 50.2 (9.9)
Socio-economic status number (%)
- low 28 (16)
- middle 76 (44)
- high 35 (20)
- unknown 35 (20)
Vision number
- normal 121
- abnormal/no glasses1 2
- adequate correction with glasses 6
- abnormal with glasses 0
- unknown 20
Sense of hearing number
- normal 123
- abnormal/no hearing aid1 4
- adequate correction with hearing aid 3
- abnormal with hearing aid 1
- unknown 18
*One sample t-test: P < 0.001; ** P < 0.05; *** P < 0.02
1in one child with severe cerebral palsy correction was not possible
BMI = body mass index; SD = standard deviation.Critical Care    Vol 13 No 2    Nijhuis-van der Sanden et al.
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Only 12% of the children had cognitive or behavioural prob-
lems without motor problems.
None of the six children with cerebral infarction (four with
MAS, one with CDH, one with PPH; Table 1) showed normal
development. Four had severe problems in all three domains,
one child had severe motor problems (hemiparesis) and one
child had severe behavioural problems. Of the nine children
with cerebral haemorrhage, four scored in the normal domain,
three had abnormal development in all three domains, one
child had borderline motor problems and one child combined
motor and cognitive problems. Six children had clinical insults:
four had normal outcome, one had severe cognitive problems
and one had severe behavioural problems. Of the 28 children
with neonatal seizures shown on electroencephalography
(EEG) only nine had normal development, 17 had motor prob-
lems (seven severe in more domains, three borderline motor
combined with borderline cognitive and/or behavioural prob-
lems, seven borderline motor problems) and two had mild cog-
nitive problems.
For the total group no significant relations were found between
MABC total impairment scores, socio-economic status or
growth outcomes. Negative outcome on the MABC was sig-
nificantly related to lower IQ-score (r = 0.48, P < 0.001), and
significantly but weakly related to lower behavioural scores (r
= 0.18, P < 0.05), although lower IQ-scores were significantly
related to negative behavioural outcome (r = 0.32, P < 0.001)
and SD height (r = 0.23, P < 0.01).
Discussion
This study presents five-year outcomes of a nationwide popu-
lation of 224 neonates treated with VA-ECMO. Severe disabil-
ities in all domains were found in 13.3% of the 174 surviving
children. More than half of those with deviant motor perform-
ance outcome (26%) had cognitive problems and/or behav-
ioural problems. Children with MAS or PPH had the best
outcomes (52% normal). Children with CDH had the worst
outcomes (only 37.5% normal in three domains), with more
problems in the motor domain, combined with decreased
growth. Although not significantly different, cognitive problems
Figure 2
Results of movement assessment battery for all children in each primary diagnosis group Results of movement assessment battery for all children in each primary diagnosis group. Chi-squared test (observed vs expected distribution): * P 
< 0.001 ** P < 0.002 *** P < 0.05. One child with pulmonary hypoplasia is not presented in the figure (all scores within the normal range). CDH = 
congenital diaphragmatic hernia; MAS = meconium aspiration syndrome; PPH = persistent pulmonary hypertension.
Motor performance outcome
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were most frequent in the MAS group (18.4%). Perinatal cer-
ebral abnormalities and neonatal seizures as measured by
EEG were highly related to deviant outcome.
In this study 24 children (14%) were lost to follow-up. These
children did not differ in perinatal or ECMO characteristics,
and the percentage of CDH children was somewhat lower and
the number of non-native children was higher in the non-
responder group. We cannot exclude that outcome will be
somewhat worse as a result of disproportionately prevalent
poorer outcome in the hard-to-trace subgroups.
The use of standardised tests allowed the comparison of this
sample with an age-related reference population. We opted
for the MABC because children may have motor performance
problems even if the neurological examination is normal [25].
In the MABC assessment protocol children are provoked to
perform age-related functional skills as fast and accurately as
possible, comparable with the demands in daily life [26], and
these demands lace more load on the neurological system.
The literature contains a few earlier, similar studies. ECMO
survivors in the UK were tested at ages four and seven years
with standardised tests for cognitive and behavioural assess-
ment, with the addition of MABC components at the age of
seven years [11,14].
Glass and colleagues [7,13] published two studies focusing
on five-year outcome using the same protocols. Controls were
recruited from a local paediatric practice. Both studies
showed major disability in 17% of the ECMO patients (vs.
13% in our study), motor disability was present in 5 to 6% of
the children, and was related to cerebral palsy.
The incidence of severe disability in our study is comparable
with that in the study by Glass and colleagues, [7,13] but
somewhat higher than in the UK study group (2%). Motor per-
formance problems seem to be more frequent in the UK study
group (57 % vs. 33% in our study) [14]. Although similar, the
studies are hardly comparable because of different types of
control groups, differences in test age, differences in decision
rules (means and SD of MABC scores underlined the deci-
sions in the UK study) and selection bias (a selection of MABC
test items in the UK study and tasks not related to daily activity
in the study by Glass and colleagues). Therefore, we would
like to advocate the use of normal-referenced tests to estimate
motor performance in the same manner as IQ tests. Another
explanation for different findings could be the difference in pri-
mary diagnoses in the above mentioned studies.
Functional motor problems interfere with the acquisition of
everyday skills and cognitive and social-emotional develop-
ment in preterm children [27]. In the present study motor prob-
Table 3
Outcome of neonatal ECMO intervention at the age of five years for the total group and specific diagnosis groups
Total group
n = 224
MAS
n = 94
CDH
n = 62
Sepsis
n = 25
PPH
n = 34
Other diagnosis
n = 9
N % N % N% N% N% N %
Children died 50 22.3 6 6.4 26 41.9 5 20.0 7 20.6 6* 66.6
Survivors n = 174
24 missing
n = 88
12 missing
n = 36
4 missing
n = 20
4 missing
n = 27
2 missing
n = 3
2 missing**
Survivors classified 150 100 76# 100 32 100 16 100 25 100 1 100
Children with severe problems in 2 or 3 domains 20 13.3 6 7.9 5 15.6 4 25 5 20
Children with mildly delayed motor development combined 
with mildly delayed cognitive development and/or behavioural 
development
13 8.7 6 7.9 2 6.2 2 12.5 3 12
Children with mildly delayed motor development and normal 
cognitive and behavioural development
26 17.3 10 13.2 11 34.4 1 6.2 4 16
Children with normal motor development, but mildly delayed 
cognitive or behavioural development
18 12 14 18.4 2 6.2 2 12.5 0 0
Children with normal development in three domains 
(MABC > p15; IQ > -1 SD; CBCL > p25)
73 48.7 40 52.6 12 37.5 7 43.8 13 52 1** 100
* diagnosis: 1 Cystic adenomatoid malformation of the lung; 1 pulmonary hypoplasia, 2 pertussis; 1 Idiopathic Pulmonary Hypertension, 1 Acute 
respiratory distress syndrome
** diagnosis: pulmonary hypoplasia
# inclusive one child not in follow-up with a known syndrome
CBCL = child behaviour checklist; CDH = congenital diaphragmatic hernia; ECMO = extracorporeal membrane oxygenation; IQ = intelligence 
quotient; MABC = movement assessment battery for children; MAS = meconium aspiration syndrome; PPH = persistent pulmonary hypertension; 
SD = standard deviation.Critical Care    Vol 13 No 2    Nijhuis-van der Sanden et al.
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lems often went together with cognitive and/or behavioural
problems and total MABC scores were significantly related to
IQ scores. Although we did not find lower IQ scores on the
RAKIT, it should be borne in mind that the predominance of
motor morbidity at age five years is likely in part to be due to
the relatively young age of the cohort. It is conceivable that
increased subtle/cognitive morbidity will become more evident
with age, when more academic and cognitive skills are
required. Moreover, the short version of the RAKIT focuses on
general intelligence and appears relatively insensitive to frontal
lobe dysfunction. The UK studies support the hypothesis that
motor problems influence the learning of cognitive skills in
which movement planning is an important factor: at the age of
four years, the ECMO children had specific problems with pat-
tern construction and copying [11], and at the age of seven
years had problems with writing [14]. Glass and colleagues
also found that the ECMO children had a two-fold risk for aca-
demic difficulties at school age and a higher rate of behav-
ioural problems [13].
Bulas and Glass reported that the severity of neonatal brain
injury was predictive for neuromotor outcome at five years of
age [28]. Still, they also found evidence of compensation fol-
lowing moderate or severe brain injury. A limitation of the
present study is the absence of neuro-imaging data in all sur-
vivors. However, we found that clinical insults and neonatal
seizures on EEG, besides cerebral infarction and haemor-
rhage, were predictive for adverse outcome. Future research
should focus on the precise diagnostics of neonatal injuries
and on the presence and influence of therapy programs and/
or differences in parental care. These would gain insight into
factors improving long-term outcome.
In the present study children born with severe pulmonary hypo-
plasia or large diaphragmatic defects were at higher risk for
motor performance problems. They often also had cognitive
and/or behavioural problems and growth scores below -1 SD,
indicative of failure to thrive. Studies focusing on long-term
morbidity in the CDH population are scarce. Hayward [29] and
colleagues found a ventilation/perfusion mismatch and
decreased postnatal lung growth in more than half of CDH
patients at age one to two years, possibly caused by a limited
catch-up growth in the postnatal period. Hamutku [30] and
colleagues found lung dysfunction (airway obstruction, hyper-
inflation and hypoxia at rest) at the age of 9 to 13 years in 50
neonatal ECMO survivors with various primary diagnoses.
They could not confirm differences in outcome related to pri-
mary diagnosis, possible as a result of the small number of
children. Boykin and colleagues found abnormalities in base-
line and post-exercise pulmonary functions in 10 to 15-year-
old ECMO children with MAS as primary diagnosis [31]. In a
multicentre, prospective study it was found that reduction in
pulmonary function at eight years was linked to ECMO itself,
CDH and small for gestational age [32]. Taken together, it can
be concluded that although pulmonary dysfunction seems to
be more serious in children with CDH, the ECMO treatment
itself also increases risk of pulmonary problems. Future studies
are needed into the relations between persistently reduced
lung capacity, growth problems and conditional restrictions in
motor activities in the ECMO population as a whole and the
CDH population in particular.
In the absence of a matched control group it remains difficult
to establish the extent to which ECMO treatment itself contrib-
utes to the outcome. The UK ECMO trial [1,3,14] did show a
benefit for ECMO based on the primary outcome "death or
severe disability". In a recent Cochrane review it was estab-
lished that this is particularly true for infants with no specific
problem of lung formation (CDH) [33]. In a recent review
focusing on the benefits of ECMO in infants with CDH, Morini
and colleagues [34] concluded that ECMO leads to a reduc-
tion in mortality. However, in very severe CDH patients this
may lead to long-term disability [31,34]. Unfortunately, at this
moment most studies concentrate on the first years after
ECMO and not on long-term outcome. The scattered data indi-
cate substantial morbidity in long-term survivors of ECMO
especially in CDH, including pulmonary damage and neuro-
cognitive defects.
In this study we can confirm that the worst outcome was found
in the CDH population: almost 42% of the children died as a
neonate, 72% had growth problems, almost 16% had severe
disabilities and another 6% had borderline problems in all
domains, 34% had borderline motor problems and only 37.5%
functioned in the normal domain. Although the outcome for
children with MAS was much better, only 53% of the survivors
functioned in the normal domain. Although no significant mor-
bidity was seen in children with sepsis, PPH or other diagnosis
was also relatively high. In particular children with MAS seem
to profit from ECMO intervention and less severe problems are
present. The MAS children are the most healthy children in
which neurological outcome is determined by an increased
risk of perinatal and neonatal hypoxaemia in the first days of
life. These children seem to have more diffuse problems in cer-
ebral information processing such as diminished ball and bal-
ance skills, and relatively more cognitive and behavioural
problems, also reported in children with mild or severe
asphyxia during birth.
Conclusions
This study shows considerable morbidity in ECMO-treated
survivors at age five years, which is not greatly different from
that reported in previous publications. Decreased motor per-
formance is the most frequent complication, often associated
with problems in the cognitive and behavioural domains. The
manual dexterity activities are less affected and ball skills and
balance skills are most affected. These functional motor prob-
lems could interfere with the acquisition of everyday skills, and
with later cognitive and social-emotional development. We,
therefore, think that longer follow-up of children at risk of mor-Available online http://ccforum.com/content/13/2/R47
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bidity at age five years is required. In particular, the CDH group
is at high risk because of failure to thrive. Moreover, perinatal
cerebral complications, such as cerebral infarction, cerebral
haemorrhage and neonatal seizures at the EEG, were predic-
tive of an adverse outcome. Brain damage and pulmonary dys-
function seem to be important determinants. Precise
registration of interventions and long-term outcomes are nec-
essary for scientific evaluation and clinical management of the
sequelae and the developmental problems. As local patient
groups are usually small, national and international collabora-
tion is recommended. We believe that a successful follow-up
programme of the ECMO population should be structured in
consultation with representatives from different disciplines
such as paediatricians, paediatric physical therapists and psy-
chologists. Improvement of long-term outcome requires not
only insight into the primary diagnosis-related factors, the
ECMO intervention related factors but also insight into factors
stimulating recovery.
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